TuHURA Biosciences Innovates with U.S. Patent for Delta Opioid Receptor Antibody Technology #United_States #Tampa #Cancer_Immunotherapy #TuHURA_Biosciences #DOR_Technology

TuHURA Biosciences Innovates with U.S. Patent for Delta Opioid Receptor Antibody Technology #United_States #Tampa #Cancer_Immunotherapy #TuHURA_Biosciences #DOR_Technology
TuHURA Biosciences Achieves Significant FDA Milestone for TBS-2025, Targeting Blood Cancers #USA #Tampa #TuHURA_Biosciences #TBS-2025 #VISTA-inhibiting_antibody
TuHURA Biosciences to Showcase Innovative Cancer Solutions at Annual Conference #USA #New_York #Cancer_Immunotherapy #TuHURA_Biosciences #IFx-2.0